Technology
A third round of software enhancements has been made to the iLab System 1.3, an ultrasound imaging system designed to strengthen physician confidence in the diagnosis and intervention of percutaneous coronary intervention (PCI) and increase workflow efficiency.
February 10, 2008
News
February 11, 2008 - The first patient was successfully treated in AtriCure’s ABLATE clinical trial designed to evaluate ...
February 10, 2008
Technology
GE's Innova BiPlane cardiovascular imaging system is one of the first digital flat panel biplane systems with a full ...
February 10, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
February 11, 2008 - Battlefield Imaging of Ringgold, GA, has become the first facility in the U.S. to install the MAGNETOM ESSENZA magnetic resonance imaging (MRI) system from Siemens Healthcare, designed to be an affordable 1.5 Tesla system.
February 10, 2008News
February 11, 2008 - Leman Cardiovascular’s animal studies to evaluate the performance in both the aortic and mitral ...
February 10, 2008News
February 11, 2008 – Medrad Inc. today said it entered into a definitive merger agreement to acquire Possis Medical Inc., which in combination will offer a broader, more comprehensive suite of products to the cardiovascular intervention field.
February 10, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024Technology
Toshiba’s Cardio Prospective helps reduce patient radiation dose by up to 80 percent during coronary CTA exams by using a helical acquisition technique to provide one continuous image instead of multiple images produced by the current step-and-shoot technique.
February 10, 2008News
February 11, 2008 - Having a heart attack is apparently not sufficient reason for most people to change to a heart-healthy diet, a new study finds. "We found that diet quality is poor after a coronary heart disease event," said study author Yunsheng Ma, M.D., an assistant professor of medicine at the University of Massachusetts Medical School, in Worcester.
February 10, 2008Technology
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
February 07, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
February 7, 2008 - Volcano Corp. said the FDA cleared the s5-Revo and s5-FFR (fractional flow reserve) options, enabling ...
February 07, 2008News
February 8, 2008 - CryoLife Inc. received 510(k) clearance from the FDA for its CryoValve SG pulmonary human heart valve processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
February 07, 2008Technology
Emageon's HeartSuite offers cardiovascular information management, hemodynamic monitoring, advanced visualization and content management. Emageon’s architecture combines HeartSuite with radiology and other medical specialties designed to offer a comprehensive patient–centric view of the visual medical record. One suite of integrated, enterprise cardiology tools includes:
February 07, 2008Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
February 07, 2008Technology
CryoLife Inc.'s CryoValve SG pulmonary human heart valve is processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
February 07, 2008News
February 8, 2008 – CryoLife Inc. said it received FDA 510(k) clearance for its CryoValve SG pulmonary human heart valve ...
February 07, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now